U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07035470) titled 'Biological Age Predicts 90-Day Mortality in Advanced Cancer: A Retrospective Study' on June 16.
Brief Summary: This retrospective study evaluates whether biological age, calculated using the PhenoAge model, predicts short-term outcomes in patients with advanced cancer who were hospitalized. The main goal is to investigate associations between biological age and short-term mortality, functional status (ECOG), comorbidity burden (mCCI), and length of hospital stay. All data were collected from medical records without any patient intervention.
Study Start Date: Nov. 05, 2022
Study Type: OBSERVATIONAL
Condition:
Advanced Solid Tumor...